Impaired ADP channeling to mitochondria and elevated reactive oxygen species in hypertensive hearts

Amelia S C Power1, Toan Pham2, Denis S Loiselle3

  • 1School of Biological Sciences, Faculty of Science, The University of Auckland, Auckland, New Zealand; and Department of Physiology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand;

Insights

Hypertension damages heart mitochondria, increasing reactive oxygen species (ROS) and impairing energy transfer. This study reveals impaired mitochondrial-myofibril connectivity contributes to heart failure in hypertensive rats.

Area of Science:

  • Cardiovascular Physiology
  • Mitochondrial Biology
  • Heart Failure Pathophysiology

Background:

  • Systemic hypertension leads to cardiac hypertrophy, eventually progressing to heart failure.
  • Energetic deficits are implicated in heart failure, but mitochondrial-myofibril energy transfer is understudied.

Purpose of the Study:

  • To investigate the role of mitochondrial-myofibril connectivity in the energetic deficits of hypertensive heart failure.
  • To compare mitochondrial function and energy transfer in hypertensive rats versus normotensive controls.

Main Methods:

  • Comparison of left ventricular (LV) homogenates and permeabilized fibers from spontaneously hypertensive rats (SHRs) and Wistar controls.
  • Assessment of mitochondrial respiration, reactive oxygen species (ROS) production, and ADP channeling using enzymatic systems.
  • Confocal imaging to measure distances between mitochondria and myofibrils.

Main Results:

  • SHR hearts exhibited 35% depressed mitochondrial function and doubled ROS production.
  • Impaired ADP channeling and reduced creatine kinase activity were observed in SHR fibers.
  • Confocal imaging revealed a 34% increase in the distance between myofibrils and mitochondria in SHR hearts.

Conclusions:

  • Impaired connectivity between mitochondria and myofibrils may contribute to elevated ROS production in hypertensive hearts.
  • Ultrastructural changes in hypertrophy likely impair energy exchange, exacerbating heart failure progression.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.5K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K